Q3  2024 |
≡ |
Greenhaven Associates |
Add 1.46% |
242,545 |
0.18 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 0.19% |
1,692 |
0.01 |
Q2  2024 |
≡ |
Greenhaven Associates |
Add 2.14% |
349,086 |
0.29 |
Q1  2024 |
≡ |
Michael Burry - Scion Asset Management |
Add 25.00% |
25,000 |
1.53 |
≡ |
Greenhaven Associates |
Add 1.11% |
178,455 |
0.10 |
Q4  2023 |
≡ |
Greenhaven Associates |
Add 22.40% |
2,948,512 |
1.62 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 21.20% |
778,922 |
0.67 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 0.37% |
6,902 |
0.02 |
≡ |
Michael Burry - Scion Asset Management |
Buy |
100,000 |
5.44 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
7,369 |
0.01 |
Q3  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 24.99% |
376,413 |
0.91 |
≡ |
Greenhaven Associates |
Add 20.00% |
2,193,883 |
1.17 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 2.85% |
101,769 |
0.07 |
≡ |
Kahn Brothers Group |
Add 0.74% |
8,878 |
0.06 |
Q2  2023 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 914.84% |
1,357,616 |
3.48 |
≡ |
Leon Cooperman |
Add 77.22% |
305,000 |
0.76 |
≡ |
Greenhaven Associates |
Add 8.82% |
889,450 |
0.54 |
Q1  2023 |
≡ |
Greenhaven Associates |
Add 31.23% |
2,399,160 |
1.75 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 9.28% |
12,600 |
0.26 |
≡ |
Bill Miller - Miller Value Partners |
Add 6.66% |
68,614 |
0.20 |
≡ |
Kahn Brothers Group |
Add 4.20% |
49,021 |
0.33 |
≡ |
Warren Buffett - Berkshire Hathaway |
Add 0.16% |
89,000 |
0.00 |
Q4  2022 |
≡ |
Lee Ainslie - Maverick Capital |
Add 34.15% |
2,075 |
0.00 |
≡ |
Greenhaven Associates |
Add 6.32% |
456,730 |
0.37 |
≡ |
Kahn Brothers Group |
Add 0.49% |
5,741 |
0.03 |
Q3  2022 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 24.93% |
1,000,000 |
1.04 |
≡ |
Greenhaven Associates |
Add 10.09% |
661,950 |
0.58 |
≡ |
Kahn Brothers Group |
Add 4.31% |
47,993 |
0.31 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
6,076 |
0.01 |
Q2  2022 |
≡ |
Leon Cooperman |
Add 107.89% |
205,000 |
0.65 |
≡ |
Samantha McLemore - Patient Capital Management |
Add 30.58% |
31,800 |
0.72 |
≡ |
Greenhaven Associates |
Add 22.18% |
1,191,580 |
1.18 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Add 20.31% |
29,700 |
0.11 |
≡ |
Kahn Brothers Group |
Add 14.67% |
142,651 |
0.88 |
≡ |
Bill Miller - Miller Value Partners |
Add 11.77% |
114,262 |
0.29 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 5.61% |
114,945 |
0.24 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 1.78% |
69,990 |
0.08 |
Q1  2022 |
≡ |
Bill Miller - Miller Value Partners |
Add 1665.10% |
915,807 |
1.86 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Add 631.00% |
126,200 |
0.39 |
≡ |
Greenhaven Associates |
Add 18.66% |
844,900 |
1.20 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 9.09% |
170,742 |
0.31 |
≡ |
Kahn Brothers Group |
Add 8.77% |
78,359 |
0.53 |
≡ |
Samantha McLemore - Patient Capital Management |
Buy |
104,000 |
2.19 |
≡ |
Warren Buffett - Berkshire Hathaway |
Buy |
55,155,797 |
0.81 |
Q4  2021 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 12.87% |
214,258 |
0.42 |
≡ |
Kahn Brothers Group |
Add 7.31% |
60,852 |
0.50 |
≡ |
Greenhaven Associates |
Buy |
4,527,140 |
6.91 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Buy |
20,000 |
0.08 |
Q3  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Add 1307.62% |
35,685 |
0.03 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 20.74% |
285,954 |
0.70 |
≡ |
Bill Nygren - Oakmark Select Fund |
Add 2.07% |
80,010 |
0.11 |
Q2  2021 |
≡ |
Thomas Gayner - Markel Group |
Add 1.94% |
400 |
0.00 |
≡ |
Kahn Brothers Group |
Add 0.72% |
6,023 |
0.06 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.19% |
1,306 |
0.00 |
Q1  2021 |
≡ |
Lee Ainslie - Maverick Capital |
Add 221.04% |
8,028 |
0.01 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 7.25% |
93,172 |
0.31 |
≡ |
Leon Cooperman |
Add 2.70% |
10,000 |
0.05 |
≡ |
Kahn Brothers Group |
Add 1.73% |
14,124 |
0.16 |
Q4  2020 |
≡ |
Greenhaven Associates |
Add 121.36% |
2,548,880 |
2.96 |
≡ |
Bill Miller - Miller Value Partners |
Add 17.36% |
112,687 |
0.23 |
Q3  2020 |
≡ |
Lee Ainslie - Maverick Capital |
Add 35.16% |
20,630 |
0.02 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 9.12% |
107,421 |
0.34 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.47% |
3,032 |
0.01 |
Q2  2020 |
≡ |
Lee Ainslie - Maverick Capital |
Add 325.32% |
44,874 |
0.05 |
≡ |
Harry Burn - Sound Shore |
Add 39.42% |
214,700 |
1.10 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.59% |
3,760 |
0.01 |
Q1  2020 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 27.72% |
332,525 |
0.90 |
≡ |
Thomas Gayner - Markel Group |
Add 11.32% |
2,300 |
0.00 |
≡ |
John Armitage - Egerton Capital |
Buy |
2,981,856 |
1.30 |
≡ |
Lee Ainslie - Maverick Capital |
Buy |
13,794 |
0.01 |
Q4  2019 |
≡ |
Thomas Gayner - Markel Group |
Add 11.83% |
2,150 |
0.00 |
Q3  2019 |
≡ |
Thomas Gayner - Markel Group |
Add 13.07% |
2,100 |
0.00 |
≡ |
Greenhaven Associates |
Add 0.12% |
14,187 |
0.02 |
Q2  2019 |
≡ |
Kahn Brothers Group |
Add 19.84% |
182,664 |
1.60 |
≡ |
Thomas Gayner - Markel Group |
Add 18.42% |
2,500 |
0.00 |
≡ |
Bill Miller - Miller Value Partners |
Add 0.56% |
3,625 |
0.01 |
Q1  2019 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Add 18.93% |
225,467 |
0.71 |
≡ |
Harry Burn - Sound Shore |
Add 14.58% |
152,800 |
0.54 |
≡ |
Bill Miller - Miller Value Partners |
Add 1.61% |
10,250 |
0.03 |
Q4  2018 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 33.75% |
348,156 |
0.89 |
≡ |
ValueAct Capital |
Add 20.21% |
5,300,000 |
3.44 |
≡ |
Thomas Gayner - Markel Group |
Add 14.32% |
1,700 |
0.00 |
≡ |
Kahn Brothers Group |
Add 1.94% |
18,050 |
0.17 |
≡ |
Steven Romick - FPA Crescent Fund |
Add 1.32% |
69,373 |
0.04 |
Q3  2018 |
≡ |
Thomas Gayner - Markel Group |
Add 66.71% |
4,750 |
0.00 |
≡ |
ValueAct Capital |
Add 4.17% |
1,050,000 |
0.74 |
≡ |
Glenn Greenberg - Brave Warrior Advisors |
Buy |
1,387,683 |
4.24 |
Q2  2018 |
≡ |
ValueAct Capital |
Add 55.40% |
8,975,500 |
5.44 |
≡ |
Leon Cooperman |
Add 37.81% |
258,600 |
0.60 |
≡ |
Harry Burn - Sound Shore |
Add 5.27% |
59,750 |
0.21 |
≡ |
Bruce Berkowitz - Fairholme Capital |
Buy |
235,000 |
2.11 |
≡ |
Thomas Gayner - Markel Group |
Buy |
7,120 |
0.01 |
Q1  2018 |
≡ |
ValueAct Capital |
Add 1372.73% |
15,100,000 |
10.22 |
≡ |
Leon Cooperman |
Add 426.08% |
553,900 |
1.40 |
Q4  2017 |
≡ |
ValueAct Capital |
Buy |
1,100,000 |
0.83 |
≡ |
Leon Cooperman |
Buy |
130,000 |
0.37 |
Q3  2017 |
≡ |
Harry Burn - Sound Shore |
Add 4.57% |
51,450 |
0.19 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 2.55% |
31,081 |
0.11 |
Q1  2017 |
≡ |
Richard Pzena - Hancock Classic Value |
Add 11.21% |
130,651 |
0.41 |
Q3  2016 |
≡ |
Harry Burn - Sound Shore |
Add 9.28% |
109,750 |
0.29 |